13F Holdings
中文EN

YI 111, Inc. Annual reports only

Retail-Drug Stores and Proprietary Stores · Nasdaq · SEC CIK 1738906 · Reporting currency CNY · Fiscal year ends 12/31

Financial factors as of 2021-12-31 (FY2021), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY51.5%
TTM net income YoY-27.0%
TTM EPS YoY-45.8%
Revenue 3-yr CAGR90.9%
Net income 3-yr CAGR—

Margins

Gross margin5.0%
Operating margin-5.2%
Net margin-4.8%
FCF margin-6.0%
EBITDA margin-4.9%

Returns

ROE-644.5%
ROA-19.2%
ROIC (approx.)—
Asset turnover4.03x

Leverage & solvency

Liabilities / assets73.0%
Debt / equity—
Current ratio1.32x
Interest coverage-117.01x

Cash quality & payout

Operating cash flow / net income1.16x
Accruals ratio3.1%
Payout ratio—
Capex / revenue0.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: CNY FY2025*2025-12-31FY2024*2024-12-31FY2023*2023-12-31FY2022*2022-12-31FY2021*2021-12-31
Income statement
Revenue12.56B14.40B14.95B13.52B12.43B
Cost of revenue11.83B13.57B14.10B12.68B11.80B
Gross profit723.41M829.23M848.98M839.98M621.10M
SG&A expense69.46M70.91M224.20M205.62M206.98M
Operating income-2.38M2.11M-350.10M-371.00M-642.14M
Interest expense35.57M28.33M20.14M13.44M5.49M
Pretax income-22.50M-20.68M-353.18M-376.07M-621.02M
Income tax13,00096,000251,00000
Net income-18.42M-12.38M-336.60M-360.79M-593.21M
EBITDA9.46M19.08M-328.32M-330.18M-614.92M
EPS (basic)-0.38-0.38-2.33-2.50-4.04
EPS (diluted)-0.38-0.38-2.33-2.50-4.04
Weighted avg. shares (diluted)174.03M171.84M168.61M166.63M165.87M
Balance sheet
Cash & equivalents510.97M462.29M603.52M716.79M760.67M
Short-term investments50.03M—50.14M205.86M182.56M
Receivables259.69M413.10M536.82M488.88M404.47M
Inventory998.47M1.39B1.42B1.50B1.12B
Current assets2.12B2.65B2.93B3.24B2.80B
PP&E, net21.11M32.90M34.34M48.50M80.25M
Intangibles868,0001.44M2.26M3.27M4.91M
Total assets2.20B2.79B3.09B3.47B3.15B
Current liabilities1.95B2.34B2.75B2.73B2.13B
Short-term debt187.63M160.98M338.07M178.99M259.66M
Total liabilities1.99B2.41B2.81B2.83B2.30B
Shareholders' equity-702.23M-642.64M-583.45M-414.60M-173.32M
Cash flow statement
Operating cash flow119.14M263.02M-447.24M-23.15M-688.84M
Capital expenditure4.45M15.20M9.82M31.57M62.59M
Free cash flow114.69M247.82M-457.07M-54.73M-751.43M
Investing cash flow-53.72M37.38M151.74M-47.17M60.14M
Financing cash flow-21.19M-406.24M205.98M22.73M74.34M
Depreciation & amortization11.84M16.97M21.78M40.82M27.22M
Stock-based compensation10.05M20.15M226.69M162.07M145.59M
Share buybacks————5.89M

Free plan shows the latest 5 periods; Pro shows all 10 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, CNY, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.